315
Lu L. Effects of soya consumption for one month on steroid hormones in premenopausal women: implications for breast cancer risk reduction. Cancer Epidemiol Biomarkers Prev. 1996 Jan; 5 (1): 63–70.
Divi R. Anti-thyroid isof lavones from soybean: isolation, characterization, and mechanisms of action. Biochem Pharmacol. 1997 Nov 15; 54 (10): 1087–96.
Doerge DR, Sheehan DM. Goitrogenic and estrogenic activity of soy isoflavones. Environ Health Perspect. 2002 Jun; 110 Suppl 3: 349–53.
Yellayi S. The phytoestrogen genistein induces thymic and immune changes: a human health concern? Proc Natl Acad Sci USA. 2002 May 28; 99 (11): 7616–21.
Zoppi G. Immunocompetence and dietary protein intake in early infancy. J Pediatr Gastroenterol Nutr. 1982; 1 (2): 175–82.
Zoppi G. Gammaglobulin level and soy-protein intake in early infancy. Eur J Pediatr. 1979 Apr 25; 131 (1): 61–9.
Zoppi G. Diet and antibody response to vaccinations in healthy infants. Lancet. 1983 Jul 2; 2 (8340): 11–14.
Fort P. Breast and soy-formula feedings in early infancy and the prevalence of autoimmune thyroid disease in children. J Am Coll Nutr. 1990 Apr; 9 (2): 164–67.
Alexandersen P. Ipriflavone in the treatment of postmenopausal osteoporosis: a randomized controlled trial. JAMA. 2001 Mar 21; 285 (11): 1482–88.
White LR, Petrovitch H, Ross GW, et al. Brain aging and midlife tofu consumption. J Am Coll Nutr. 2000 Apr; 19 (2): 242–55.
Reddy ST. Effect of low-carbohydrate high-protein diets on acid-base balance, stoneforming propensity, and calcium metabolism. Am J Kidney Dis. 2002 Aug; 40 (2): 265–74.
Jenkins DJ, Kendall CW, Vidgen E, et al. Effect of high vegetable protein diets on urinary calcium loss in middle-aged men and women. Eur J Clin Nutr. 2003 Feb; 57 (2): 376–82.
Spence LA, Lipscomb ER, Cadogan J, et al. The effect of soy protein and soy isoflavones on calcium metabolism in postmenopausal women: a randomized crossover study. Am J Clin Nutr. 2005 Apr; 81 (4): 916–22.
Jenkins DJ, Kendall CW, Vidgen E, et al. Effect of high vegetable protein diets on urinary calcium loss in middle-aged men and women. Eur J Clin Nutr. 2003 Feb; 57 (2): 376–82.
Yu H. Role of the insulin-like growth factor family in cancer development and progression. J Natl Cancer Inst. 2000 Sep 20; 92 (18): 1472–89.
Arjmandi BH, Khalil DA, Smith BJ, et al. Soy protein has a greater effect on bone in postmenopausal women not on hormone replacement therapy, as evidenced by reducing bone resorption and urinary calcium excretion. J Clin Endocrinol Metab. 2003 Mar; 88 (3): 1048–54.
Yu H. Role of the insulin-like growth factor family in cancer development and progression. J Natl Cancer Inst. 2000 Sep 20; 92 (18): 1472–89.
Bartke A, Chandrashekar V, Dominici F, et al. Insulin-like growth factor 1 (IGF-1) and aging: controversies and new insights. Biogerontolog y. 2003; 4 (1): 1–8.
Miller RA. Genetic approaches to the study of aging. J Am Geriatr Soc. 2005 Sep; 53 (9 Suppl): S284–86.
Holzenberger M. The GH/IGF-I axis and longevity. Eur J Endocrinol. 2004 Aug; 151 Suppl 1: S23–7.
Sutter NB, Bustamante CD, Chase K, et al. A single IGF1 allele is a major determinant of small size in dogs. Science. 2007 Apr 6; 316 (5821): 112–15.
Samaras TT, Elrick H, Storms LH. Is height related to longevity? Life Sci. 2003 Mar 7; 72 (16): 1781–1802.
Holzenberger M. The GH/IGF-I axis and longevity. Eur J Endocrinol. 2004 Aug; 151 Suppl 1: S23–7.
Siegel-Itzkovich J. Health committee warns of potential dangers of soya. BMJ. 2005 Jul 30; 331 (7511): 254.
Turck D. Soy protein for infant feeding: what do we know? Curr Opin Clin Nutr Metab Care. 2007 May; 10 (3): 360–65.
www.wholesoystory.com/newsletters/FrenchWARNING.pdf.
www.babycareadvice.com/babycare/general_help/article.php?id=43.
Bjelakovic G, Nikolova D, Simonetti RG, Gluud C. Antioxidant supplements for prevention of mortality in healthy participants and patients with various diseases. Cochrane Database Syst Rev. 2008 Apr 16; (2): CD007176.
Bjelakovic G, Nikolova D, Simonetti RG, Gluud C. Antioxidant supplements for preventing gastrointestinal cancers. Cochrane Database Syst Rev. 2008 Jul 16; (3): CD004183.
Peto R, Doll R, Buckley JD, Sporn MB. Can dietary beta-carotene materially reduce human cancer rates? Nature. 1981 Mar 19; 290 (5803): 201–8.
Bjelke E. Dietary vitamin A and human lung cancer. Int J Cancer. 1975 Apr 15; 15 (4): 561–65.
The Alpha-Tocopherol, Beta Carotene Cancer Prevention Study Group. The effect of vitamin E and beta carotene on the incidence of lung cancer and other cancers in male smokers. N Engl J Med. 1994 Apr 14; 330 (15): 1029–35.
Omenn GS, Goodman GE, Thornquist MD, et al. Effects of a combination of beta carotene and vitamin A on lung cancer and cardiovascular disease. N Engl J Med. 1996 May 2; 334 (18): 1150–55.
The Alpha-Tocopherol, Beta Carotene Cancer Prevention Study Group. The effect of vitamin E and beta carotene on the incidence of lung cancer and other cancers in male smokers. N Engl J Med. 1994 Apr 14; 330 (15): 1029–35.
Omenn GS, Goodman GE, Thornquist MD, et al. Effects of a combination of beta carotene and vitamin A on lung cancer and cardiovascular disease. N Engl J Med. 1996 May 2; 334 (18): 1150–55.
Pietrzik K. Antioxidant vitamins, cancer, and cardiovascular disease. N Engl J Med. 1996 Oct 3; 335 (14): 1065–66.
Bjelakovic G, Gluud C. Vitamin and mineral supplement use in relation to all-cause mortality in the Iowa Women’s Health Study. Arch Intern Med. 2011 Oct 10; 171 (18): 1633–34.
Redberg RF. Vitamin supplements: more cost than value: comment on “dietary supplements and mortality rate in older women.” Arch Intern Med. 2011 Oct 10; 171 (18): 1634–35.
Lee JE, Chan AT. Fruit, vegetables, and folate: cultivating the evidence for cancer prevention. Gastroenterolog y. 2011 Jul; 141 (1): 16–20.
Pietrzik K. Antioxidant vitamins, cancer, and cardiovascular disease. N Engl J Med. 1996 Oct 3; 335 (14): 1065–66.
Lippman SM, Klein EA, Goodman PJ, et al. Effect of selenium and vitamin E on risk of prostate cancer and other cancers: the Selenium and Vitamin E Cancer Prevention Trial (SELECT). JAMA. 2009; 301: 39–51.
Klein EA, Thompson IM Jr, Tangen CM, et al. Vitamin E and the risk of prostate cancer. The Selenium and Vitamin E Cancer Prevention Trial (SELECT). JAMA. 2011 Oct 12; 306 (14): 1549–56.
Heart Protection Study Collaborative Group. MRC/BHF Heart Protection Study of antioxidant vitamin supplementation in 20,536 high-risk individuals: a randomised placebo-controlled trial. Lancet. 2002 Jul 6; 360 (9326): 23–33.
Rapola JM, Virtamo J, Ripatti S, et al. Randomised trial of alpha-tocopherol and betacarotene supplements on incidence of major coronary events in men with previous myocardial infarction. Lancet. 1997 Jun 14; 349 (9067): 1715–20.
Mursu J, Robien K, Harnack LJ, et al. Dietary Supplements and Mortality Rate in Older Women: The Iowa Women’s Health Study. Arch Intern Med. 2011 Oct 10; 171 (18): 1625–33.
Lonn E, Bosch J, Yusuf S, et al; HOPE and HOPE-TOO Trial Investigators. Effects of long-term vitamin E supplementation on cardiovascular events and cancer: a randomized controlled trial. JAMA. 2005 Mar 16; 293 (11): 1338–47.
Lange H, Suryapranata H, De Luca G, et al. Folate therapy and in-stent restenosis after coronary stenting. N Engl J Med. 2004 Jun 24; 350 (26): 2673–81.
Bønaa KH, Njølstad I, Ueland PM, et al; NORVIT Trial Investigators. Homocysteine lowering and cardiovascular events after acute myocardial infarction. N Engl J Med. 2006 Apr 13; 354 (15): 1578–88.
Albert CM, Cook NR, Gaziano JM, et al. Effect of folic acid and B vitamins on risk of cardiovascular events and total mortality among women at high risk for cardiovascular disease: a randomized trial. JAMA. 2008 May 7; 299 (17): 2027–36.
Durga J, Bots ML, Schouten EG, et al. Effect of 3 y of folic acid supplementation on the progression of carotid intima-media thickness and carotid arterial stiffness in older adults. Am J Clin Nutr. 2011 May; 93 (5): 941–49.
Study of the Effectiveness of Additional Reductions in Cholesterol and Homocysteine (SEARCH) Collaborative Group, Armitage JM, Bowman L, Clarke RJ, et al. Effects of homocysteine-lowering with folic acid plus vitamin B12 vs placebo on mortality and major morbidity in myocardial infarction survivors: a randomized trial. JAMA. 2010 Jun 23; 303 (24): 2486–94.
House AA, Eliasziw M, Cattran DC, et al. Effect of B-vitamin therapy on progression of diabetic nephropathy: a randomized controlled trial. JAMA. 2010 Apr 28; 303 (16): 1603–9.
Sanders KM, Stuart AL, Williamson EJ, et al. Annual high-dose oral Vitamin D and falls and fractures in older women: a randomized controlled trial. JAMA. 2010 May 12; 303 (18): 1815–22.
Graat JM, Schouten EG, Kok FJ. Effect of daily vitamin E and multivitamin-mineral supplementation on acute respiratory tract infections in elderly persons: a randomized controlled trial. JAMA. 2002 Aug 14; 288 (6): 715–21.
Pittas AG, Chung M, Trikalinos T, et al. Systematic review: Vitamin D and cardiometabolic outcomes. Ann Intern Med. 2010 Mar 2; 152 (5): 307–14.
Grey A, Bolland MJ, Reid IR. Vitamin D supplementation. Arch Intern Med. 2010 Mar 22; 170 (6): 572–73.
Glerup H, Mikkelsen K, Poulsen L, et al. Commonly recommended daily intake of vitamin D is not sufficient if sunlight exposure is limited. J Internal Med. 2000; 247: 260–68.
Holick MF. Vitamin D: a millenium perspective. J Cell Biochem. 2003; 88: 296–307.
Reichrath J. The challenge resulting from positive and negative effects of sunlight: how much solar UV exposure is appropriate to balance between risks of vitamin D deficiency and skin cancer? Prog Biophys Mol Biol. 2006 Sep; 92 (1): 9–16.
Reusch J, Ackermann H, Badenhoop K. Cyclic changes of vitamin D and PTH are primarily regulated by solar radiation: 5-year analysis of a German (50 degrees N) population. Horm Metab Res. 2009 May; 41 (5): 402–7.
Salamone LM, Dallal GE, Zantos D, et al. Contributions of vitamin D intake and seasonal sunlight exposure to plasma 25-hydroxyvitamin D concentration in elderly women. Am J Clin Nutr. 1994 Jan; 59 (1): 80–86.
Vieth R. Vitamin D supplementation, 25-hydroxyvitamin D concentrations, and safety. Am J Clin Nutr. 1999; 69: 84256.
Holick MF. Sunlight Dilemma: risk of skin cancer or bone disease and muscle weakness. Lancet. 2001; 357: 46.
Wolpowitz D, Gilchrest BA. The vitamin D questions: how much do you need and how should you get it? J Am Acad Dermatol. 2006 Feb; 54 (2): 301–17.
Wolpowitz D, Gilchrest BA. The vitamin D questions: how much do you need and how should you get it? J Am Acad Dermatol. 2006 Feb; 54 (2): 301–17.
Lucas RM, Repacholi MH, McMichael AJ. Is the current public health message on UV exposure correct? Bull World Health Organ. 2006 Jun; 84 (6): 485–91.
Wharton JR, Cockerell CJ. The sun: a friend and enemy. Clin Dermatol. 1998 Jul – Aug; 16 (4): 415–19.
Porojnicu A, Robsahm TE, Berg JP, Moan J. Season of diagnosis is a predictor of cancer survival. Sun-induced vitamin D may be involved: a possible role of sun-induced Vitamin D. J Steroid Biochem Mol Biol. 2007 Mar; 103 (3–5): 675–78.
Robsahm TE, Tretli S, Dahlback A, Moan J. Vitamin D3 from sunlight may improve the prognosis of breast-, colonand prostate cancer (Norway). Cancer Causes Control. 2004 Mar; 15 (2): 149–58.
Zhou W, Suk R, Liu G, et al. Vitamin D is associated with improved survival in earlystage non-small cell lung cancer patients. Cancer Epidemiol Biomarkers Prev. 2005 Oct; 14 (10): 2303–9.
Berwick M, Armstrong BK, Ben-Porat L, et al. Sun exposure and mortality from melanoma. J Natl Cancer Inst. 2005 Feb 2; 97 (3):195–99.
